FDA Orange Book · active-ingredient family
Dorzolamide hydrochloride; timolol maleate
Dorzolamide hydrochloride; timolol maleate is approved as 2 brand and 20 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:COSOPT PF · NDA 202667
2
Brand (NDA)
20
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · solution/drops
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| COSOPT PFRLD | THEA PHARMA | NDA 202667 | AT2 | Feb 01, 2012 | |
| COSOPTRLD | THEA PHARMA | NDA 020869 | AT1 | Apr 07, 1998 |
Generic (ANDA) products (20)
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Dorzolamide hydrochloride; timolol maleate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

